{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:38:58Z","timestamp":1788435538909,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["POIG.01.01.02-00-069\/09"],"award-info":[{"award-number":["POIG.01.01.02-00-069\/09"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.pharep.2015.03.022","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T07:31:23Z","timestamp":1429255883000},"page":"811-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Detrimental effects of chemotherapeutics and other drugs on the endothelium: A call for endothelial toxicity profiling"],"prefix":"10.1007","volume":"67","author":[{"given":"Tomasz","family":"Wojcik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Szczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Chlopicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2015.03.022_bib0375","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.0000025404.78001.D8","article-title":"Prognostic value of coronary vascular endothelial dysfunction","volume":"106","author":"Halcox","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2015.03.022_bib0380","first-page":"86","article-title":"Angiotensin converting enzyme (ACE) reductase inhibitors in the forefront of pharmacology of endothelium","volume":"56","author":"Ch\u0142opicki","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2015.03.022_bib0385","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"Fitzgerald","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2015.03.022_bib0390","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40262-013-0071-8","article-title":"Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective","volume":"52","author":"Mohammadpour","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharep.2015.03.022_bib0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ctrv.2011.09.002","article-title":"Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications","volume":"38","author":"Soultati","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.pharep.2015.03.022_bib0400","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1634\/theoncologist.2010-0348","article-title":"Cardiovascular complications of breast cancer therapy in older adults","volume":"16","author":"Shenoy","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.pharep.2015.03.022_bib0405","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","article-title":"Daunomycin an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia","volume":"20","author":"Tan","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.pharep.2015.03.022_bib0410","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1200\/JCO.1998.16.11.3493","article-title":"Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients","volume":"16","author":"Shapiro","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0415","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.pharep.2015.03.022_bib0420","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/1097-0142(19931115)72:10<3120::AID-CNCR2820721038>3.0.CO;2-Q","article-title":"Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol","volume":"72","author":"Steinherz","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.pharep.2015.03.022_bib0425","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2015.03.022_bib0430","first-page":"96","article-title":"Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact?","volume":"26","author":"Ewer","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0435","first-page":"1147","article-title":"Endothelial dysfunction as a determinant of trastuzumab-mediated cardiotoxicity in patients with breast cancer","volume":"1152","author":"Sandoo","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharep.2015.03.022_bib0440","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.ATV.0000030186.66672.36","article-title":"Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor\/vascular endothelial growth factor receptor pathway in cancer patients","volume":"22","author":"Kuenen","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0445","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/02841860802314720","article-title":"Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis","volume":"48","author":"Zhu","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0450","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2007.11.0106","article-title":"Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility","volume":"25","author":"Telli","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0455","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0753-3322(02)00242-1","article-title":"Atherosclerosis and cancer: common pathways on the vascular endothelium","volume":"56","author":"Morganti","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2015.03.022_bib0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pharep.2015.03.022_bib0465","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbagen.2005.10.012","article-title":"The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction","volume":"1760","author":"Wolf","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharep.2015.03.022_bib0470","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.redox.2013.01.014","article-title":"Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms","volume":"1","author":"Kalyanaraman","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-3623(98)00100-1","article-title":"Dexrazoxane (ICRF-187)","volume":"32","author":"Weiss","year":"1999","journal-title":"Gen Pharmacol Vasc Syst"},{"key":"10.1016\/j.pharep.2015.03.022_bib0480","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.bjp.0706953","article-title":"Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide","volume":"149","author":"Damrot","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0485","doi-asserted-by":"crossref","first-page":"e76676","DOI":"10.1371\/journal.pone.0076676","article-title":"Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells","volume":"8","author":"Vavrova","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pharep.2015.03.022_bib0490","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.pharep.2015.03.022_bib0495","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0500","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0167-4781(92)90050-A","article-title":"Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development","volume":"1132","author":"Capranico","year":"1992","journal-title":"Biochim Biophys Acta \u2013 Gene Struct Expr"},{"key":"10.1016\/j.pharep.2015.03.022_bib0505","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.pharep.2015.03.022_bib0510","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tiv.2014.12.009","article-title":"Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells","volume":"29","author":"Wojcik","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.pharep.2015.03.022_bib0515","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1039\/C4AN01882F","article-title":"Raman microspectroscopic investigation on nuclear accumulation of doxorubicin, daunorubicin and their epimers in endothelium; relationship with cytotoxicity","volume":"140","author":"Majzner","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.pharep.2015.03.022_bib0520","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0968-0004(00)89082-9","article-title":"Out of the shadows and into the light: the emergence of DNA repair","volume":"20","author":"Friedberg","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharep.2015.03.022_bib0525","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1065521","article-title":"ATR and ATRIP: partners in checkpoint signaling","volume":"294","author":"Cortez","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharep.2015.03.022_bib0530","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2011.02.036","article-title":"Induction of ER stress protects gastric cancer cells against apoptosis induced by cisplatin and doxorubicin through activation of p38 MAPK","volume":"406","author":"Feng","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharep.2015.03.022_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2012.11.003","article-title":"Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells","volume":"1","author":"Diers","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0540","first-page":"2931","article-title":"Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer","volume":"24","author":"Faneyte","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharep.2015.03.022_bib0545","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/jpet.113.206805","article-title":"A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin","volume":"347","author":"Bains","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2015.03.022_bib0550","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0058421","article-title":"Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse","volume":"8","author":"Toldo","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pharep.2015.03.022_bib0555","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10623320490904124","article-title":"Differential toxicity of anthracyclines on cultured endothelial cells","volume":"11","author":"Kaushal","year":"2004","journal-title":"Endothelium"},{"key":"10.1016\/j.pharep.2015.03.022_bib0560","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejca.2003.12.012","article-title":"Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer","volume":"40","author":"Nuver","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pharep.2015.03.022_bib0565","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1538-7836.2007.02788.x","article-title":"Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity","volume":"5","author":"Lechner","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.pharep.2015.03.022_bib0570","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF01744983","article-title":"Vitamin E prevents endothelial injury associated with cisplatin injection into the superior mesenteric artery of rats","volume":"10","author":"Ito","year":"1995","journal-title":"Heart Vessels"},{"key":"10.1016\/j.pharep.2015.03.022_bib0575","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/cncr.23389","article-title":"Cardiovascular risk in long-term survivors of testicular cancer","volume":"112","author":"Vaughn","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.pharep.2015.03.022_bib0580","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1014059528046","article-title":"Gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor","volume":"4","author":"Basaki","year":"2001","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharep.2015.03.022_bib0585","first-page":"1191","article-title":"Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center","volume":"1","author":"Hotchkiss","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharep.2015.03.022_bib0590","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FJC.0b013e3181d263f7","article-title":"Paclitaxel potentiates inflammatory cytokine-induced prothrombotic molecules in endothelial cells","volume":"55","author":"Wood","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0595","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3565(25)38491-0","article-title":"Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury","volume":"268","author":"Kachel","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2015.03.022_bib0600","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00252982","article-title":"Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy","volume":"19","author":"Samuels","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0605","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9149(96)00380-3","article-title":"Depression and long-term mortality risk in patients with coronary artery disease","volume":"78","author":"Barefoot","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0610","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jacc.2005.05.041","article-title":"Impaired endothelial function in coronary heart disease patients with depressive symptomatology","volume":"46","author":"Sherwood","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0615","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PSY.0000000000000062","article-title":"Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression","volume":"76","author":"Bouzinova","year":"2014","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pharep.2015.03.022_bib0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.1255","article-title":"Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence","volume":"20","author":"Baldwin","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharep.2015.03.022_bib0625","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.08.001","article-title":"The impact of prenatal stress on insulin-like growth factor-1 and pro-inflammatory cytokine expression in the brains of adult male rats: the possible role of suppressors of cytokine signaling proteins","volume":"276","author":"Szczesny","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0630","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/ndt\/16.10.1968","article-title":"Endothelial dysfunction and inflammation \u2013 is there a link?","volume":"16","author":"Stenvinkel","year":"2001","journal-title":"Nephrol Dial Transpl"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2015.03.022_bib0635","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2015.03.022_bib0640","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hup.915","article-title":"Cardiac side effects of psychiatric drugs","volume":"23","author":"Mackin","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0645","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fpsyt.2014.00137","article-title":"Increased mortality in schizophrenia due to cardiovascular disease \u2013 a non-systematic review of epidemiology, possible causes, and interventions","volume":"5","author":"Ringen","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pharep.2015.03.022_bib0650","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2011.03.031","article-title":"Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs)","volume":"130","author":"Ellingrod","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharep.2015.03.022_bib0655","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2011.02.007","article-title":"Peripheral endothelial dysfunction in patients suffering from acute schizophrenia: a potential marker for cardiovascular morbidity?","volume":"128","author":"Israel","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharep.2015.03.022_bib0660","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.64.2.242","article-title":"Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database","volume":"64","author":"Osborn","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"1188","key":"10.1016\/j.pharep.2015.03.022_bib0665","first-page":"e1","article-title":"Chronic escitalopram treatment induces erectile dysfunction by decreasing nitric oxide bioavailability mediated by increased nicotinamide adenine dinucleotide phosphate oxidase activity and reactive oxygen species production","volume":"82","author":"Kassan","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.pharep.2015.03.022_bib0670","first-page":"119","article-title":"Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro \u2013 the role of the endothelium","volume":"63","author":"Ribback","year":"2012","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0675","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2125.1999.00002.x","article-title":"Relaxant effects of antidepressants on human isolated mesenteric arteries","volume":"48","author":"Vila","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0680","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","article-title":"Platelet\/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2015.03.022_bib0685","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease","volume":"279","author":"Roose","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pharep.2015.03.022_bib0690","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharep.2015.03.022_bib0695","article-title":"Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010","volume":"18","author":"Spindelegger","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0700","series-title":"Rang and Dale's pharmacology","author":"Rang","year":"2012"},{"key":"10.1016\/j.pharep.2015.03.022_bib0705","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1043-6618(03)00093-8","article-title":"Contradictory effects of chlorpromazine on endothelial cells in a rat model of endotoxic shock in association with its actions on serum TNF-\u03b1 levels and antioxidant enzyme activities","volume":"48","author":"Can","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2015.03.022_bib0710","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1139\/cjpp-2013-0185","article-title":"Atypical antipsychotics such as risperidone, but not paliperidone, worsen vascular endothelial function via upregulation of adhesion molecules VCAM-1, ICAM-1, and E-selectin in diabetic rats","volume":"91","author":"Aboul-Fotouh","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0715","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1570159X11209040328","article-title":"The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress","volume":"10","author":"Martinc","year":"2012","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0720","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharep.2015.03.022_bib0725","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/dom.12356","article-title":"The paradox of bardoxolone methyl: a call for every witness on the stand?","volume":"17","author":"Van Laecke","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharep.2015.03.022_bib0730","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.taap.2013.06.019","article-title":"Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes","volume":"272","author":"Nadanaciva","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pharep.2015.03.022_bib0735","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrd2446","article-title":"Microscopic imaging techniques for drug discovery","volume":"7","author":"Bullen","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharep.2015.03.022_bib0740","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.2011.01255.x","article-title":"How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?","volume":"163","author":"Laverty","year":"2011","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:02Z","timestamp":1752611762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.03.022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1734114015000699"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.03.022","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detrimental effects of chemotherapeutics and other drugs on the endothelium: A call for endothelial toxicity profiling","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}